¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mu chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
¿µ¹® hyaline membrane disease ÇÑ±Û À¯¸®Áú¸·º´
¼³¸í   
  ÇãÆÄ ¼º¼÷µµÀÇ ¹Ì¼÷À¸·Î ÇãÆÄ²Ê¸®¸¦ ÆØÃ¢½Ã۴ ¹°Áú(Ç¥¸éȰ¼ºÁ¦)ÀÌ ºÎÁ·ÇÏ¿© È£Èí°ï¶õÀÌ ÃÊ·¡µÇ´Â º´À¸·Î¼­ ¹Ì¼÷¾Æ¿¡ È£¹ßÇϴµ¥, Ãâ»ý½Ã ÀӽűⰣº¸´Ùµµ ÇãÆÄ ¼º¼÷ Á¤µµ°¡ ´õ °ü¿©µÈ´Ù. ´ÜÀÏ º´À¸·Î¼­´Â »ç¸Á·üÀÌ °¡Àå ³ôÀ¸¸ç(¾à 30%), ½Å»ý¾ÆÀÇ ´ëÇ¥ÀûÀΠº´ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¹Ì¼÷¾Æ, »ýÈÄ 6~8½Ã°£³» È£Èí°ï¶õÁõ¼¼ ÃâÇö°ú »ýÈÄ 24~48½Ã°£ÀÇ Áõ»ó ¾ÇÈ­, »ýÈÄ 2~3Àϰ£ ÀΰøÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇÏÁö ¾ÊÀ¸¸é È£ÈíÀ» °è¼Ó½Ãų ¼ö°¡ ¾øÀ¸¸ç Á¡Á¡´õ »ê¼ÒÀÇ °ø±Þ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸ç, µ¿¸ÆÇ÷¾×¼ÓÀÇ »ê¼Ò³óµµ°¡ ³»·Á°¡°í ÀÌ»êȭź¼ÒÀÇ ³óµµ°¡ ³ôÀ¸¸ç, ÈäºÎ ¹æ»ç¼± ¼Ò°ßÀ» ÂüÀÛÇÏ¿© Áø´ÜÇÑ´Ù. È¯¾Æ´Â ¼÷·ÃµÈ °£È£ Àη°ú Ã·´Ü ÀÇ·á Àåºñ°¡ ¼³Ä¡µÈ ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç¿¡¼­ Ä¡·áÇÏ¿©¾ß ÇÑ´Ù. ¿¹ÈĴ Áõ¼¼ÀÇ °æÁß¿¡ µû¶ó ´Ù¸£°í »ç¸Á·üÀº 30~50% µÈ´Ù. ¾î¶² ¾Æ±â¿¡ À־´Â Ä¡·á ÈÄ¿¡ ´«À̳ª ±â°üÁöÇãÆÄ °èÅë¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â »ê¼ÒÁßµ¶ÁõÀÌ º¸°íµÇ°í ÀÖ´Ù.
¿µ¹® fibrocystic disease of breast ÇÑ±Û À¯¹æ ¼¶À¯³¶º´
¼³¸í   
  Á¥À» »ý»êÇϴ Á¥»ù³»¿¡ ¿ÏµÎÄᠶǴ ūÄá Å©±âÀÇ °áÀýÀÌ ¹ß»ýÇϴ Áõ¼¼¸¦ Æ¯Â¡À¸·Î Çϴ º´. 30~50´ëÀÇ ºÎÀο¡°Ô ÈçÈ÷ ¹ß»ýÇϸç, ±× ´ëºÎºÐÀº ¾çÂÊ À¯¹æ¿¡ µ¿½Ã¿¡ ¹ß»ýÇÑ´Ù. ÀÌ·¯ÇÑ °áÀýÀº µÎ ¼Õ°¡¶ô »çÀÌ¿¡ ³¢¿ö ÃËÁøÇÒ ¶§´Â ºÐ¸íÇÏÁö¸¸, È亮À» ¼Õ¹Ù´ÚÀ¸·Î ´©¸£¸é ¸í·áÇÏÁö ¾ÊÀ» Á¤µµ·Î ºÎµå·¯¿î °ÍÀÌ ¸¹´Ù. ±× ¹ß»ý ¿øÀο¡´Â ¿©·¯ °¡Áö ¼³ÀÌ ¸¹Àºµ¥, Á¥»ùÁ¶Á÷¿¡ ´ëÇÑ ¸¸¼ºÀûÀΠÀÚ±ØÀÌ ÁÖ¿øÀÎÀ̶ó »ý°¢µÇ°í ÀÖÀ¸¸ç, ±ØÈ÷ ¼­¼­È÷ ÁøÇàÇϴ °æ°ú¸¦ ¹â´Â´Ù. Áø´ÜÀº ÃËÁø, ÃÊÀ½ÆÄÁø´Ü µîÀ¸·Î Çϸç, ¾Ï°ú °¨º°ÀÌ °ï¶õÇÒ ¶§´Â Á¶Á÷ÀÇ ÀϺθ¦ Ã¤ÃëÇÏ¿© °Ë»çÇϴ »ý°ËÀÌ ÀÌ¿ëµÇ±âµµ ÇÑ´Ù.
¿µ¹® periodontal disease ÇÑ±Û Ä¡ÁÖº´
¼³¸í   
  ÀÕ¸ö°ú Ä¡¾Æ, ±×¸®°í ±× ÁÖÀ§ »ÀÀÇ ¿°Áõ°ú ÅðÇ༺ º¯È­¸¦ ¸»ÇÔ. Ä¡·á¿¡ À־ ÀÕ¸öÀÇ Á¦°Å°¡ ÇʼöÀûÀÌ´Ù. ÀÕ¸öÀÇ Á¦°Å´Â »õ·Î¿î ÀÕ¸öÀÇ »ý¼ºÀ» Á¶ÀåÇÑ´Ù.
¿µ¹® Crohn's disease ÇÑ±Û Å©·Ðº´
¼³¸í   
  ¸¸¼ºÀûÀ̰í Àç¹ßÀ» ÀßÇϴ âÀÚÀÇ ¿°ÁõÀ» Æ¯Â¡À¸·Î Çϴ º´. ÀåÀÇ º®Àº ¾ÈÂÊ¿¡¼­ºÎÅÍ Á¡¸·, Á¡¸·ÇÏÁ¶Á÷, ±ÙÀ°Ãþ, À帷ÀÇ 4°³ÀÇ ÃþÀ¸·Î ÀÌ·ç¾îÁ® Àִµ¥, Å©·Ðº´Àº ÀÌ ¸ðµç ÃþÀÇ ¿°ÁõÀ» µ¿¹ÝÇÑ´Ù. ÀåÀÇ ¸ðµç ºÎºÐ¿¡¼­ »ý±æ ¼ö°¡ ÀÖÁö¸¸ ÁַΠ¸·Ã¢ÀÚ¿Í ¿¬°áµÇ´Â Å«Ã¢ÀÚÀÇ ¸»´ÜºÎ¿¡ °¡Àå ¸¹ÀÌ »ý±ä´Ù. Ã¢ÀÚÀÇ ÀüÃþÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ÀåÀÇ Æó¼â³ª ±«¾çÀ» ¸¸µé¸ç Á¾Á¾ Ãµ°øµÈ´Ù.
¿µ¹® Paget's disease ÇÑ±Û ÆÄÁ¦Æ®º´
¼³¸í   
  1. »ÀÆÄÁ¦Æ®º´. º¯Çü¼º »À¿°. »ÀÈí¼ö ÈÄ »ÀÇü¼ºÀÌ ¹Ýº¹ÀûÀ¸·Î °úµµÇϰԠÀϾ´Â °ÍÀ¸·Î, »õ·Ó°Ô Çü¼ºµÈ »À´Â ¹«Áú¼­Ç졒ʱ¸Á¶ÀûÀ¸·Î °ß°íÇÏÁö ¸øÇÏ´Ù. »ÀÈí¼öÀÇ Áõ°¡°¡ ¹Ýº¹µÇ°í À̾ °úÀ׺¸¼ö¸¦ ²ÒÇÏ¿© ¾àÇ졒ʼ¯ÇüµÈ »ÀÀÇ ºÎÇǰ¡ Áõ°¡µÇ´Â °ÍÀ» Æ¯Â¡À¸·Î Çϴ »Àº´ÀÌ´Ù. ±ÃµÕ»ÀÀÇ ¸¸°î, ÆíÆò»ÀÀÇ º¯ÇüÀ» ÀÏÀ¸Å°°í, µ¿Åë ¹× º´Àû °ñÀýÀ» ¼ö¹ÝÇÑ´Ù. 2. À¯¹æÆÄÁ¦Æ®º´. Á¥²ÉÆÇ ¹× Á¥²ÀÁöÀÇ ¿°Áõ¼º ¾Ï¼º Áúº´À¸·Î¼­ º¸ÅëÀº Á¥»ù ¹× À¯¹æ ±íÀº °÷ÀÇ ¾ÏÀ» µ¿¹ÝÇÑ´Ù. º¸Åë Áß³âºÎÀο¡°Ô ¹ß»ýÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • bird fancier¡¯s disease
    Á¶·ù»çÀ°ÀÚº´
  • bleeder¡¯s disease
    Ç÷¿ìº´, ÃâÇ÷¼ºÈ¯ÀÚº´
  • blue disease
    û»öº´
  • Bowen¡¯s disease
    º¸¿£º´
  • Buerger¡¯s disease
    ¹ö°Åº´
  • climatic disease
    ±âÈĺ´
  • cold agglutinin disease
    Àú¿ÂÀÀÁýº´
  • collagen disease
    Äݶó°Õº´
  • collagen-vascular disease
    Äݶó°ÕÇ÷°üº´, ±³¿øÇ÷°üº´
  • comb disease
    ´ßº­½½º´
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·º´
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • carcinoid heart disease
    À¯¾Ï½ÉÀ庴
  • cardiovascular disease
    ½ÉÀåÇ÷°üº´
  • cat-scratch disease
    °í¾çÀ̱ÜÈûº´
  • celiac disease
    ¸¸¼º¼ÒÈ­Àå¾ÖÁõ, ¼Ò¾ÆÁö¹æº¯(Áõ), º¹ºÎÁúº´
  • central core disease
    Áß½ÉÇÙº´
  • cerebrovascular disease
    ³úÇ÷°üº´, ³úÇ÷°üÁúȯ
  • cervical disease
    Àڱøñº´, ÀڱðæºÎº´, ÀڱðæºÎÁúȯ
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ, ¸¸¼ºÆó¼âÆóº´
  • climatic disease
    ±âÈĺ´
  • cold agglutinin disease
    Àú¿ÂÀÀÁýº´
  • cold hemagglutinin disease
    Àú¿ÂÇ÷±¸ÀÀÁý¼Òº´, ÇÑ·©ÀûÇ÷±¸ÀÀÁýº´
  • collagen disease
    ¾Æ±³Áúº´
  • collagen-vascular disease
    ¾Æ±³ÁúÇ÷°üº´, ±³¿øÇ÷°üº´
  • comb disease
    ´ßº­½½º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Chiari-Frommel disease
    Ű¾Æ¸®ÇÁ·Ò¸áº´.
  • Chicago disease
    ½ÃÄ«°íº´.
  • Christmas disease
    Å©¸®½º¸¶½ºº´
  • Christmas disease
    Å©¸®½º¸¶½º º´
  • Christmas disease=hemophilia B
    Å©¸®½º¸¶½ºº´=Ç÷¿ìº´ B
  • Clostridial disease
    Ŭ·Î½ºÆ®¸®µð¿òº´
  • Coats disease
    ÄÚ¿ìÃ÷º´
  • Coats disease
    ÄÚ¿ìÃ÷º´
  • Corvisart s disease
    ÄÚ¸£ºñÀÚ¸£º´.
  • Coutons disease
    ÄíÅ뺴.
  • Creutzfeld-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®-¾ßÄߺ´.
  • Creutzfeld-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®-¾ßÄߺ´.
  • Creutzfeldt-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®-¾ßÄß º´
  • Creutzfeldt-Jakob disease(CJD)
    Å©·ÎÀÌÃ÷ÆçÆ®¾ßÄߺ´
  • Crohns disease
    Å©·Ðº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • mu (¥ì) chain
    ¹Â»ç½½, ¹Â¼â
  • multiple chain
    º¹½Ä(ÜÜãÒ)»ç½½.
  • nuclear chain
    Çٻ罽, ÇÙ¼â(ú·áð).
  • nuclear chain fiber
    Çٻ罽±ÙÀ°¼¼Æ÷
  • open chain compound
    ¿­¸°»ç½½È­ÇÕ¹° °³¼âÈ­ÇÕ¹°(ËÒáðûùùêÚª) .
  • open chain form
    ¿­¸°»ç½½Çü.
  • ossicular chain
    À̼Ұñ¿¬¼â, °í½ÇÀÛÀº»À°í¸®{ÇØ}
  • ossicular chain reconstruction
    À̼Ұñ¿¬¼âÀç°Ç
  • oxidative chain
    »êÈ­¿¬¼â.
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    Á¾ÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction (PCR)
    ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction(PCR)
    ÁßÇÕ ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction=PCR
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • chain propagation
    »ç½½ Áõ½Ä(ñòãÖ)
  • chain reaction
    ¿¬¼â¹ÝÀÀ(ææáðÚãëë)
  • chain termination
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ)
  • chain termination codon
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) ÄÚµç
  • chain termination mutation
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) º¯ÀÌ(ܨì¶)
  • chain terminator
    »ç½½Çü¼º(û¡à÷) Á¾·áÀÚ(ðûÖõí­)
  • chain terminator method
    »ç½½Çü¼º(û¡à÷) Á¾·áÀÚ¹ý(ðûÖõí­Ûö)
  • closed chain
    "´ÝÈù »ç½½, Æó¼â(øÍáð) (ÔÒ) ring"
  • decay chain
    "ºØ±«(ÝÚÎÕ) »ç½½, (ÔÒ) radioactive series"
  • delta chain
    µ¨Å¸ »ç½½
  • DNA polymerase chain reaction
    DNA Æú¸®¸Ó·¹À̽º ¿¬¼â ¹ÝÀÀ(ææáðÚãëë) (ÔÒ) polymerase chain reaction
  • electron transfer chain
    ÀüÀÚÀü´Þ(ï³í­îîÓ¹) »ç½½
  • electron transport chain
    ÀüÀÚ¼ö¼Û(ï³í­âÃáê) »ç½½
  • end carbon chain
    ³¡Åº¼Ò(÷©áÈ) »ç½½
  • epsilon chain
    ÀԽǷР»ç½½
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Tietzes disease+B701
    ƼÂź´
  • underlying disease
    ¿øÁúȯ, ±âÃÊÁúȯ
  • valvular disease
    ÆÇ¸·Áõ
  • valvular heart disease
    ÆÇ¸·¼º½ÉÁúȯ
  • wasting disease
    ¼Ò¸ðº´
  • Wilson's disease
    Àª½¼º´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LCDD light chain deposition disease
AR   1) Aortic Regurgitation
    = AI
  Echo¼Ò°ß
 &...
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
IHD Ischemic Heart Disease
  = Coronary Heart(Artery) Disease
  = Atheroscler...
LCP Disease Legg-Calve-Perthes Disease
  ? Stages of LCP Disease(= Juvenile Idiopathic AVN)
&nb...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
HC Heavy chain
HCD Heavy chain diseases
IL-2Rbeta IL)-2 receptor beta chain
IL-4R alpha IL)-4 receptor alpha chain
IL-2R alpha IL-2 receptor alpha chain
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • black disease
    Èæ»ö º´
    ¾çÀÇ Àü¿°¼º ±«»ç¼º °£¿°. ¹Ì±¹, ¿À½ºÆ®·¹Àϸ®¾Æ¿¡¼­ÀÇ ¾çÀÇ Ä¡»çº´ÀÌ¸ç ¶§¶§·Î »ç¶÷¿¡°Ôµµ »ý±ä´Ù. °£ÀåÀÇ ±«»ç°¡ ±× Ư¡ÀÌ¸ç ³ëºñ±Õ¿¡ ÀÇÇÏ¿© ÀϾ´Ù.
  • bleeder's disease
    Ç÷¿ìº´
    ÃâÇ÷À» Àß ÀÏÀ¸Å°°Å³ª ÃâÇ÷ ¼ÒÁúÀÌ ÀÖ´Â Áúº´.
  • Blocq's disease
    ºí·Ï º´
    µ¿ÀǾî=astasia, abasia.
  • blood disease
    Ç÷¾× ÀÌ»ó
    µ¿ÀǾî=hemic disease.
  • bone disease
    °ñ Áúȯ
    µ¿ÀǾî=osteo
  • Bowen's disease
    º¸À¢ º´, º¸À¢ Áúȯ
    1. À¯¿øÇüÀÇ °æ°è. ¼±¸íÇÑ Èë°¥»ö ³»Áö °¥»öÀÇ ±¹¼ÒÀû º´º¯À» Çü¼ºÇÑ´Ù. ±¸°­ Á¡¸·ÀÇ Àû»ö, ¹é»ö ¹ÝÁ¡À¸·Î ¶Ñ·ÇÇÑ ºÒ±ÔÄ¢ÇÑ ¼ºÀåÀ» ÇÑ´Ù. °¡Çǰ¡ µ¤È÷¸é¼­ ¿ø½É»óÀ¸·Î È®´ëÇϴµ¥ Ç¥ÇÇ ³»¾ÏÀÇ »óŸ¦ À¯ÁöÇÏ¸ç ±âÀúÃþ¿¡ ÆÄ±«, Áõ½Ä, ÀüÀ̸¦ ³ªÅ¸³»´Â °ÍÀº »ó´çÈ÷ ÁøÇàÇÑ °æ¿ìÀÌ´Ù. Ä¡·á¹ýÀ¸·Î¼­´Â ÀýÁ¦, Ç×¾ÏÁ¦ ¿¬°í°¡ »ç¿ëµÈ´Ù. 2. ³»Àå ¾Ï°ú °ü·Ã ÀÖ´Â ºñħÀ±¼º ¾ÏÁ¾À¸·Î µå¹°°Ô ¹ß»ýÇÏ¸ç ³²¼º, ¿©¼º ¸ðµÎ ¼º±â¿¡ ¹ß»ýÇÑ´Ù. 3. »óÇdz»ÀÇ ¾Ç¼º Á¾¾çÀÌ´Ù. ¾Ç¼º ¼ºÀåÀº °Ç°­ÇÑ ±âÀú¸·°ú ÇÔ²² »óÇÇ¿¡ Á¦ÇѵȴÙ. ÇǺδ ¸î °³ÀÇ À¶±âµÈ Á¡À» µ¿¹ÝÇÑ Ã¤ ºÓ°Ô ³ªÅ¸³ª¸ç ºÎºÐÀûÀ¸·Î Àμ³ÀÌ Çü¼ºµÇ¾î ÀÖ°í ºÎºÐÀûÀ¸·Î Á¥¾î ÀÖ´Ù. Áß¾Ó¿¡ À§ÃàÀ̳ª ±Ë¾çÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. 4. ºñ±³Àû µå¹® ÁúȯÀ¸·Î ³ëÃâ ¶Ç´Â ºñ³ëÃâ ºÎÀ§¿¡ »ý±æ ¼ö ÀÖ´Ù. º´º¯Àº ÀÛ°í
  • Brill-Zinsser disease
    Brill-Zinsser º´
    ¹ßÁøÆ¼Çª½º¿¡ °É·È´ø ȯÀÚ¿¡¼­ ¹ß»ýµÇ´Â Àç¹ßÇüÀÇ º´À¸·Î ¸®ÄÉÄ¡¾Æ±ÕÀº º´ÀÌ ³ªÀº ÈÄ¿¡µµ ¼ö ½Ê³â°£ Áõ»ó ¾øÀÌ ¸²ÇÁÀý ¼Ó¿¡ Á¸¼ÓÇÒ ¼ö ÀÖ´Ù.
  • Buergers disease
    ¹ö°Å º´
  • bullous disease
    ¼öÆ÷¼º Áúȯ
  • bullous skin disease
    ¼öÆ÷¼º ÇǺΠÁúȯ
  • calcific mitral disease
    ¼®È¸È­ ½Â¸ðÆÇ¸· Áúȯ
  • caloric disease
    °í¿Â º´
    °í¿Â¿¡ ³ëÃâµÇ¾î ³ªÅ¸³ª´Â Áúȯ.
  • Canavan's disease
    Ä«³ª¹Ý º´
    »ó¿°»öü ¿­¼º À¯ÀüÇÏ´Â ÁúȯÀ¸·Î ¾Æ½ºÆÄ¸£Å侯½Ç¶óÁ¦
  • Castleman disease
    Castleman º´
    °Å´ë ¸²ÇÁÀý Áõ½Ä ¶Ç´Â ¸²ÇÁÀý °ú¿ÀÁ¾ µîÀ¸·Îµµ ºÒ¸®¿ì´Â ÀÌ ÁúȯÀº Çö¹Ì°æ ¼Ò°ß¿¡ µû¶ó À¯¸®Áú Ç÷°üÇü°ú ÇüÁú ¼¼Æ÷Çü µÎ À¯ÇüÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. À¯¸®Áú Ç÷°üÇüÀº ´Ù¾çÇÑ Å©±âÀÇ ¿©Æ÷·Î ±¸¼ºµÇ°í ÁÖÀ§¿¡ ¿ÜÅõÃþ ¸²ÇÁ±¸ÀÇ Áõ½ÄÀ¸·Î µ¿½É¿øÇüÀÇ ¹è¿­ÀÌ °üÂûµÈ´Ù. ¿©Æ÷ Áß½ÉÀº Ç÷°ü Áõ½Ä°ú Ç÷°ü º®ÀÇ À¯¸®Áú º¯È­·Î µÎ²¨¿öÁ® Hassall ¼Òü¿Í À¯»çÇÏ´Ù. ¿©Æ÷ »çÀÌ °£Áú Á¶Á÷¿¡´Â Ç÷°ü Áõ½Ä°ú ÇÔ²² ÇüÁú ¼¼Æ÷, ¸é¿ª¸ð¼¼Æ÷, È£»ê±¸°¡ ħÀ±ÇÑ´Ù. ÀÓ»óÀû Áõ»óÀÌ ¾øÀÌ ÇÑ °³ÀÇ Á¾±«·Î ³ªÅ¸³ª´Â °æ¿ì¿¡ 90% Á¤µµ°¡ ÃÊÀÚ¾ç Ç÷°üÇüÀ̰í Á¾°Ýµ¿¿¡ È£¹ßÇÏ¸ç ±×¹Û¿¡ °æºÎ, ¾×¿ÍºÎ, Àå°£¸· µî¿¡¼­ ³ªÅ¸³­´Ù. Ç÷Áú¼¼Æ÷ÇüÀº ´Ù¹ß¼ºÀ¸·Î ¿­, ºóÇ÷, ÀûÇ÷±¸ ħ°­ ¼ÓµµÀÇ Áõ°¡, ¸é¿ª ±Û·ÎºÒ¸°ÀÇ Áõ°¡ µîÀÇ ÀÓ»ó Áõ»óÀ» µ¿¹ÝÇÑ´Ù. Àü½ÅÀûÀÎ ÇüÁú¼¼Æ÷ÇüÀº ºñÁ¤»óÀûÀÎ °ú¸é¿ª ¹ÝÀÀÀ¸·Î ¿¹Èİ¡ ÁÁÁö ¾ÊÀ¸¸ç ¾Ç¼º ¸²ÇÁÁ¾À̳ª Ka
  • cat-scratch disease
    °í¾çÀÌ-ÇÒÅ¡ º´, ¹¦¼Òº´
    ÀÌ ÁúȯÀº ±Þ¼º °æ°ú¸¦ ÃëÇÏ¸ç °í¾çÀÌ¿Í Á¢ÃËÇÑ ¾ÆÀ̵é°ú ÀþÀºÀÌ¿¡°Ô¼­ °¡Àå ÈçÇÏ°Ô ¹ß»ýÇÑ´Ù. ÁÖ·Î ÇÒÄû°Å³ª ´Ù¸¥ »óó¸¦ ÅëÇØ¼­ ÀüÆÄµÇÁö¸¸, °ú°Å·ÂÀÌ ¾ø´Â °æ¿ìµµ ÀÖ´Ù. °í¾çÀÌ ÇÒÅ¡ º´Àº ±×¶÷ À½¼º °£»ó±ÕÀÎ Bartonella henselae¿¡ ÀÇÇØ¼­ ÀϾ´Ù. ÇÒÄý ´ÙÀ½ ¸çÄ¥ ÈÄ 1/3¿¡¼­ Á¢Á¾ À§Ä¡¿¡ ÀÏÂ÷Àû »óó°¡ ³ªÅ¸³­´Ù. ÀÌ °÷ÀÌ °¨¿°µÈ °÷À̸ç Áß¾Ó¿¡ ¾×Æ÷³ª ³óÆ÷°¡ ÀÖ´Â °¡Çǰ¡ µ¤Èù ±Ë¾çÀ̳ª ±¸ÁøÀ¸·Î ³ªÅ¸³­´Ù. 1-3ÁÖ ÈÄ¿¡ Àü¹ÝÀûÀÎ °¨¿°ÀÇ ¾ç»óÀÌ º¸ÀÌ¸ç ±¹¼ÒÀû Àӯļ±ÀÌ Àӯļ±¿°ÀÇ ±Ù°Å°¡ ¾øÀÌ Ä¿Áø´Ù. À̰ÍÀº ¾ÐÅëÀÌ ÀÖ°í °íÁ¤µÇ¾î ÀÖÀ¸¸ç ¿°ÁõÀÌ µÚµ¤°í ÀÖ´Ù. ȤÀº ´­·¯µµ ¾ÆÇÁÁö ¾ÊÀ¸¸ç °¥¶óÁø ¾ç»óÀ¸·Î ¿°Áõ ¾ç»ó¾øÀÌ º¸ÀÏ ¼öµµ ÀÖ´Ù. ³óÀÌ »ý±â´Â °ÍÀÌ ÈçÇϸç À̰ÍÀº ¹«±Õ¼º ³óÀÇ ¾ç»óÀÌ´Ù. ÁøÇà °úÁ¤ÀÌ ¾ç¼ºÀÏÁö¶óµµ ¾î¶² °æ¿ì¿£ ¿­ÀÌ ³ª¸ç ¸î ÁÖ µ¿¾È ½ÉÇÑ Àü½Å Áõ»óÀ» º¸À̱⵵ ÇÑ´Ù. ¸²ÇÁÀý Á¾´ë ½Ã¿¡´Â ¸²ÇÁÁ¾À̳ª ´Ù¸¥ ¾Ç¼º Á¾¾ç, °áÇÙ, ¸²ÇÁ À°¾ÆÁ¾, ±Þ¼º ¼¼±Õ¼º °¨¿°°ú °¨º°ÇØ¾ß ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
immunoglobulins, light-chain Polypeptide chains, consisting of 211 to 217 amino acid residues, isolated from immunoglobulins and having a molecular weight of approximately 22 kD. There are two major types of light chains, kappa and lambda. In man they are found in a ratio of 60% to 40%, respectively. Both chains consist of linear repeating, similar, but not identical, segments of about 110 amino acid residues. In each segment a disulfide bond establishes a tightly folded approximately 60-membered loop or domain. Adjacent domains are linked by less tightly folded regions. Both light chains contain two such domains. Two light and two heavy chains make one immunoglobulin molecule, but both light chains in one ig are of the same type.
(12 Dec 1998)
immunoglobulins, mu-chain Heavy chains found in the fab and fc fragments of IgM and having a molecular weight of approximately 72 kD. They contain about 57 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IgG.
(12 Dec 1998)
invariant chain <chemical> Noncovalently associated with class II antigens, alpha and beta chain complex; involved in the regulation of malignant cell ia function; iip31 and iip33 were synthesized by using alternative initiator methionines
Synonym: II igc, ia-associated invariant chain, II invariant glycoprotein complex, class II-associated invariant chain, IIp33, IIp31, clip peptide, ln-2 antigen, ln 2 antigen, cd74 antigen, II-key, II76-92
(05 Dec 1998)
open chain compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
ossicular chain The small bones of the middle ear; they are articulated to form a chain for the transmission of sound from the tympanic membrane to the oval window.
Synonym: ossicula auditus, ear bones, ossicular chain.
(05 Mar 2000)
EDTA light chain <protein> Myosin light chains (18 kD) from scallop muscle (two per pair of heavy chains), easily extracted by calcium chelation. Although the EDTA light chains do not bind calcium they confer calcium sensitivity on the myosin heavy chains.
(18 Nov 1997)
electron transport chain <biochemistry, chemistry> A series of compounds that transfer electrons to an eventual donor with concomitant energy conversion.
One of the best studied is in the mitochondrial inner membrane, that takes NADH (from the tricarboxylic acid cycle) or FADH and transfers electrons via ubiquinone, cytochromes and various other compounds, to oxygen. Other electron transport chains are involved in photosynthesis.
(18 Nov 1997)
J chain <molecular biology> A polypeptide chain (15 kD), found in IgA and in IgM joining heavy chains (H chains) to each other to form dimers of IgA and pentamers of IgM. Disulphide bonds are formed between the J chain and H chains near the Fc ends of the heavy chains. Despite the similar name, it is not identical with the J region or coded for by the J gene.
Synonym: J piece.
(10 Jan 1998)
kappa chain <protein> Either of two types of light chains (small polypeptide chains) that are found in immunoglobulins.
(09 Oct 1997)
2-methyl branched-chain enoyl-CoA reductase <enzyme> Important in the reversal of beta-oxidation under anaerobic conditions in ascaris suum
Registry number: EC 1.3.1.52
Synonym: 2-methyl bce-CoA reductase
(26 Jun 1999)
lambda chain <immunology> Although light chains are found in many multimeric proteins, L chain usually refers to the light chains of immunoglobulins.
These are of 22 kD and of one of two types, kappa or lambda. A single immunoglobulin has identical light chains (2 kappa or 2 lamda). Light chains have one variable and one constant region. There are isotype variants of both kappa and lamda.
(25 Jun 1999)
lauric acid in-chain-hydroxylase <enzyme> Specific for lauric acid; hydroxylates at c-8, c-9 or c-10 of chain
Registry number: EC 1.14.14.-
Synonym: (cytochrome p-450)-dependent laurate in-chain-hydroxylase
(26 Jun 1999)
L chain <immunology> Although light chains are found in many multimeric proteins, L chain usually refers to the light chains of immunoglobulins.
These are of 22 kD and of one of two types, kappa or lambda. A single immunoglobulin has identical light chains (2 kappa or 2 lamda). Light chains have one variable and one constant region. There are isotype variants of both kappa and lamda.
(25 Jun 1999)
L-chain myeloma bence Jones myeloma
light chain <immunology, protein> The lighter of the two types of polypeptide chains that are found in immunoglobulin and antibody molecules.
Also used as a non-specific term for the smaller subunits of several multimeric proteins such as immunoglobulin, myosin, dynein, clathrin.
(14 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Riggs' disease
    Ä¡Á¶ ³ó·ç
  • atomic disease
    ¿øÀÚº´
  • atonic disease
    ¿øÀÚº´
  • basedows disease
    ¹ÙÁ¦µµ º´
  • caisson disease
    ÄÉÀ̽¼º´;ÀáÇÔº´
  • celiac disease
    ¼Ò¾ÆÁö¹æº¯Áõ
  • deficiency disease
    ¿µ¾ß ½ÇÁ¶;ºñŸ¹Î °áÇÌÁõ
  • disease
    º´
  • disease germ
    º´¿ø±Õ
  • duck's disease
    (ÀÍ»ì)ªÀº ´Ù¸®
  • fishskin disease
    ¾î¸°¼±
  • footandmouth disease
    ¾Æ±¸Ã¢(°¡ÃàÀÇ ÀÔÀ̳ª ¹ß±Á¿¡ »ý±â´Â Àü¿°º´)
  • footinmouth disease
    ½Ç¾ðº®
  • green monkey disease
    =MARBURG DISEASE
  • heart disease
    ½ÉÀ庴
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á